Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)
Status:
Withdrawn
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
This project is an intervention study where type 2 diabetic patients will rotate through 4
different albuminuria lowering drugs with the aim to 1) quantify the individual relationship
between drug exposure and albumin lowering response of different albuminuria lowering drugs
in type 1 and type 2 diabetics; and 2) to investigate the effect of the same drug
intervention on the glycocalyx layer in blood vessels. The overall purpose of this study is
to allow for future personalized treatment of diabetics with regards to treating kidney
disease more effectively than current standardized strategies.
Phase:
Phase 4
Details
Lead Sponsor:
Steno Diabetes Center Steno Diabetes Center Copenhagen